Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: A theoretical analysis

Transplantation

Volumn 70, Issue 7, 2000, Pages 1121-1127

  Kiberd, Bryce A ^a,c   Larson, Timothy ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; COST UTILITY ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY DISEASE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MEDICARE; NEPHROTOXICITY; PANCREAS DISEASE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROBABILITY; RETINA DISEASE; REVIEW; RISK ASSESSMENT; THEORY; TREATMENT OUTCOME; UREMIA;

EID: 0034667884     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200010150-00027     Document Type: Review

References (37)

1. Economic consequences of diabetes mellitus in the US in 1997
2. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
3. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control Complications Trial
4. Metabolic complications and prevalence of microvascular complications in young Danish patients with type 1 diabetes mellitus
5. Solitary pancreas transplantation for nonuremic patients with labile insulin dependent diabetes mellitus
6. Reversal of lesions of diabetic nephropathy after pancreas transplantation
7. Report of the International Pancreas Transplant Registry
8. Markov models in medical decision analysis: A practical guide
9. Methodology for measuring health-state preferences. II. Scaling methods
10. Recommendations of the panel on cost-effectiveness in health medicine
11. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients
12. Nephrotoxic effects of primary immunosuppression with FK506 and cyclosporine regimens after liver transplantation
13. Risks and costs of end stage renal disease after heart transplantation
14. Captopril reduces risk of nephropathy in IDDM patients with microalbuminuria
15. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
16. Impact of pancreas transplantation on diabetic secondary complications and quality of life
17. Improved survival in patients with insulin dependent diabetes mellitus and end stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation
18. Incidence and long-term cost of steroid related side effects after transplantation
19. Analysis of hospital charges after simultaneous pancreas-kidney transplantation in the era of managed care
20. Cost-effective treatment for diabetic end stage renal disease: Dialysis, kidney, or kidney pancreas transplantation
21. Pancreas transplantation for diabetes mellitus
22. Organ procurement expenditures and the role of financial incentives
23. An economic analysis of pancreas transplantation: Costs, insurance coverage, and reimbursement
24. Cost-utility analysis of living donor kidney transplantation followed by pancreas transplantation versus simultaneous pancreas kidney transplantation
25. Improvement in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts
26. Comparison of quality of life between pancreas/kidney and kidney transplant recipients: 1 Year follow up
27. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors
28. The British Diabetic Association Cohort Study, I: All-cause mortality in patients with insulin treated diabetes mellitus
29. Pancreas transplantation in the United States and Non US as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry
30. Long term function (>5 years) of pancreas grafts from the International Pancreas Transplant Registry Database
31. Predictors of mortality in insulin dependent diabetes mellitus: 10 Year observational follow up study
32. Coronary artery disease is the major determinant of excess mortality in patients with insulin dependent diabetes mellitus and persistent proteinuria
33. Model of complications of NIDDM: I. Model construction and assumptions